The majority of pediatric patients with Fanconi anemia (FA) who underwent hematopoietic stem cell transplantation (HSCT) were alive and event-free at 5 years, according to the results of a retrospective study published in the journal Blood. Researchers also found that the cumulative incidences (CINs) of primary and secondary graft failure...